✦ LIBER ✦

Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: A randomized, double-blind, placebo-controlled, phase III study

✍ Scribed by Hee Chul Eun; Oh Sang Kwon; Je Ho Yeon; Hyo Seung Shin; Byung Yoon Kim; Byung In Ro; Han Kyong Cho; Woo Young Sim; Bark Lynn Lew; Won-Soo Lee; Hwa Young Park; Seung Phil Hong; Jae Hong Ji

Book ID: 116585897
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 555 KB
Volume: 63
Category: Article
ISSN: 1097-6787
DOI: 10.1016/j.jaad.2009.09.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of solifenacin succi

Efficacy and safety of solifenacin succinate 10 mg once Daily: A multicenter, phase III, randomized, double-blind, placebo-controlled, parallel-group trial in patients with overactive bladder

✍ Franklin Chu; Neila Smith; Takeshi Uchida 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Efficacy, safety, and gastrointestinal t

Efficacy, safety, and gastrointestinal tolerability of tapentadol ER in a randomized, double-blind, placebo- and active-controlled phase III study of patients with chronic low back pain

✍ R. Buynak; D. Shapiro; A. Okamoto; C. Lange; M. Etropolski 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 35 KB

Efficacy and Tolerability of Once-Daily

Efficacy and Tolerability of Once-Daily Oral Fimasartan 20 to 240 mg/d in Korean Patients with Hypertension: Findings from Two Phase II, Randomized, Double-Blind, Placebo-Controlled Studies

✍ Howard Lee; Han-Mo Yang; Hae-Young Lee; Jae-Joong Kim; Dong-Ju Choi; Ki-Bae Seun 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 843 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis

✍ Gerald G. Krueger; Kim A. Papp; Dow B. Stough; Keith H. Loven; Wayne P. Gulliver 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 480 KB

Randomised clinical trial: a multicentre

Randomised clinical trial: a multicentre, double-blind, placebo-controlled study on the efficacy and safety of rabeprazole 5 mg or 10 mg once daily in patients with non-erosive reflux disease

✍ Y. Kinoshita; K. Ashida; M. Hongo; The Japan Rabeprazole Study Group for NERD 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB

Efficacy and safety of a once-yearly i.v

Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: A randomized, multicenter, double-blind, active-controlled study

✍ Eric S Orwoll; Paul D Miller; Jonathan D Adachi; Jacques Brown; Robert A Adler; 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 216 KB

## Abstract Zoledronic acid (ZOL) has shown beneficial effects on bone turnover and bone mineral density (BMD) in postmenopausal osteoporosis. This study compared the efficacy and safety of a once‐yearly i.v. infusion of ZOL with weekly oral alendronate (ALN) in men with osteoporosis. In this multi